10.1677/erc.1.01149 Endocr
Sin embargo, estos resultados parecen ser ms significativos cuando la suplementacin se combina con un programa de dieta y ejercicio
The rats were 8 weeks old at the initiation of the studies with a body weight of 250325 g
If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting ColonBroom GLP-1 Booster or any new supplement

[5] [2] Patients starting GLP-1 therapy should be aware of: Potential mood changes during the adjustment period, particularly if experiencing significant gastrointestinal side effects The importance of continuing existing mental health treatments unless advised otherwise by their healthcare team Realistic expectations regarding weight loss and metabolic improvements, as unrealistic goals can lead to disappointment Healthcare professionals prescribing GLP-1 agonists should: Screen for depression and anxiety at baseline and during follow-up appointments Monitor for mood changes , particularly in patients with pre-existing mental health conditions Ensure coordinated care between diabetes/obesity services and mental health teams when appropriate It is essential to recognise that GLP-1 agonists are not a substitute for evidence-based depression treatments, including psychological therapies and antidepressant medications when indicated

Many people use them for performance anxiety or situational stress, like public speaking or job interviews